Hendriks didn't have the results he wanted in his first MLB game since June 2023, but that he was back at all was worth ...

Important questions regarding the durations of response to ADC treatment, long-term safety and tolerability, and combinability with chemotherapy and other anti-lymphoma/-leukemia agents remain ...

After 680 days out of the game, Liam Hendriks finally gets to stop the clock and start anew. “That’s the exact number of days ...

Welsh rock band The Alarm followed in the footsteps of their friends U2, rising out of the fertile late 70s UK post punk ...

The incidence of non-Hodgkin’s lymphoma (NHL) is increasing among ... there is a need for the development and validation of treatment strategies for NHL for these patients.

Sana Biotechnology, Inc.’s SANA share price has surged by 7.80%, which has investors questioning if this is right time to sell.

Tennessee lawmakers adjourned for the year on April 22, concluding a session shaped by controversy over education for ...

While most patients with this type of non-Hodgkin’s lymphoma generally respond to initial treatment, the disease is prone to recurrent relapses and shorter remission periods and is ultimately ...

with the FDA approving its use alongside Roche’s Rituxan for two additional forms of indolent non-Hodgkin’s lymphoma (NHL). The pairing of Revlimid (lenalidomide) and Rituxan (rituximab ...

Ascentage Pharma Group International’s AAPG share price has surged by 11.92%, which has investors questioning if this is ...

1. Compared to receiving intravenous (directly into a vein (IV)) anti-cancer therapy in hospital outpatient clinics, we are uncertain whether receiving the same therapy at home affects the management ...